Total Payments
$6,937
2024 Payments
$1,028
Companies
27
Transactions
110
Medicare Patients
6,742
Medicare Billing
$779,212
Payment Breakdown by Category
Food & Beverage$6,932 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,932 | 109 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,361 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $925.98 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $833.12 | 7 | $0 (2024) |
| Novo Nordisk Inc | $706.42 | 8 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $307.14 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $299.73 | 5 | $0 (2024) |
| ABBVIE INC. | $297.00 | 5 | $0 (2023) |
| Lilly USA, LLC | $254.50 | 4 | $0 (2023) |
| Edwards Lifesciences Corporation | $234.61 | 3 | $0 (2024) |
| PFIZER INC. | $207.13 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($244.81) |
| 2023 | $895.63 | 17 | AstraZeneca Pharmaceuticals LP ($241.99) |
| 2022 | $990.42 | 14 | Novo Nordisk Inc ($278.04) |
| 2021 | $759.29 | 14 | Janssen Pharmaceuticals, Inc ($389.09) |
| 2019 | $709.81 | 8 | Janssen Pharmaceuticals, Inc ($245.98) |
| 2018 | $775.66 | 13 | Novo Nordisk Inc ($315.88) |
| 2017 | $1,779 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($471.83) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $152.40 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Gastroenterology | ||||||
| 08/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $12.30 | General |
| 07/24/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $129.00 | General |
| 06/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $136.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Gastroenterology | ||||||
| 04/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.81 | General |
| Category: DIABETES | ||||||
| 03/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Gastroenterology | ||||||
| 11/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Oncology | ||||||
| 09/05/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 08/09/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Hyperthyroidism | ||||||
| 08/02/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Gastroenterology | ||||||
| 06/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $121.73 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,875 | 2,848 | $467,213 | $208,966 |
| 2022 | 22 | 1,962 | 2,967 | $506,676 | $211,793 |
| 2021 | 24 | 1,502 | 2,729 | $527,631 | $193,295 |
| 2020 | 21 | 1,403 | 2,396 | $346,098 | $165,158 |
Total Patients
6,742
Total Services
10,940
Medicare Billing
$779,212
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 336 | 790 | $107,640 | $51,136 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 313 | $65,665 | $29,831 | 45.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 223 | 244 | $46,904 | $26,115 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 368 | $58,260 | $24,584 | 42.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $32,615 | $18,416 | 56.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 213 | 239 | $45,303 | $15,757 | 34.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 79 | $37,582 | $11,244 | 29.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 36 | $17,637 | $7,581 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 98 | 149 | $15,474 | $6,237 | 40.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 35 | 38 | $12,676 | $6,026 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $9,454 | $3,953 | 41.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 17 | $5,193 | $1,656 | 31.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $1,547 | $1,219 | 78.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,977 | $1,033 | 34.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 25 | $1,775 | $1,008 | 56.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 82 | $1,774 | $874.07 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 88 | $1,320 | $739.20 | 56.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 22 | $1,210 | $737.66 | 61.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 44 | $1,250 | $460.67 | 36.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 15 | 15 | $540.00 | $192.52 | 35.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 16 | $336.00 | $130.61 | 38.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 27 | $81.00 | $34.23 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 391 | 998 | $129,877 | $58,486 | 45.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 234 | 256 | $49,142 | $28,405 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 412 | $77,355 | $27,774 | 35.9% |
About Dr. Steven Morris, M.D
Dr. Steven Morris, M.D is a Hematology & Oncology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033159637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Morris, M.D has received a total of $6,937 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 110 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,932).
As a Medicare-enrolled provider, Morris has provided services to 6,742 Medicare beneficiaries, totaling 10,940 services with total Medicare billing of $779,212. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Boca Raton, FL
- Active Since 06/08/2006
- Last Updated 11/04/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033159637
Products in Payments
- XARELTO (Drug) $1,361
- JARDIANCE (Drug) $462.91
- XIFAXAN (Drug) $307.14
- FARXIGA (Drug) $305.39
- ENTRESTO (Drug) $299.73
- Rybelsus (Drug) $250.00
- PRADAXA (Drug) $245.21
- BEVESPI AEROSPHERE (Drug) $213.73
- AVEIR (Device) $152.40
- Kerendia (Drug) $150.00
- ELIQUIS (Drug) $146.81
- MOUNJARO (Drug) $134.27
- QULIPTA (Drug) $130.24
- Ozempic (Drug) $129.56
- NEXLETOL (Drug) $128.57
- KRYSTEXXA (Biological) $125.00
- RINVOQ (Biological) $125.00
- SPIRIVA RESPIMAT (Drug) $125.00
- STELARA (Biological) $125.00
- SYMBICORT (Drug) $124.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boca Raton
Mohammad Jahanzeb, Md, MD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Fernando Recio, Md, MD
Hematology & Oncology — Payments: $26,134
Hematology & Oncology $26,134
Dr. Liat Dagan, Md, MD
Hematology & Oncology — Payments: $9,194
Hematology & Oncology $9,194
Dr. Paul Hyman, Md, MD
Hematology & Oncology — Payments: $9,103
Hematology & Oncology $9,103
Dr. Bachir Berbari, Md, MD
Hematology & Oncology — Payments: $6,995
Hematology & Oncology $6,995
Dr. Aurea Tomeski, M.d, M.D
Hematology & Oncology — Payments: $22.15
Hematology & Oncology $22.15